Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for InfuSystem Holdings Inc. (INFU:NYSE), powered by AI.
InfuSystem Holdings Inc. is currently trading at $8.80. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for InfuSystem Holdings Inc. on Alpha Lenz.
InfuSystem Holdings Inc.'s P/E ratio is 27.4.
“InfuSystem Holdings Inc. trades at a P/E of 27.4 (premium valuation) with solid ROE of 11.5%.”
Ask for details →InfuSystem Holdings Inc. is a leading provider of healthcare services specializing in the supply of durable medical equipment and third-party billing services across the United States and Canada. The company's primary function is to deliver innovative solutions for patients requiring ambulatory infusion pumps for chemotherapy, pain management, and other infusion therapies. Notably, InfuSystem Holdings Inc. supports oncologists and other healthcare stakeholders in managing complex, cost-critical medical treatments outside traditional hospital settings, enhancing patient care and operational efficiencies. It also impacts sectors such as oncology, surgery centers, and home healthcare by offering reliable equipment logistics and comprehensive documentation services. In the financial market, InfuSystem Holdings Inc. represents a critical intersection of healthcare delivery and medical technology, positioning itself as a key player in facilitating advanced medical care with an emphasis on patient comfort and accessibility.
“InfuSystem Holdings Inc. trades at a P/E of 27.4 (premium valuation) with solid ROE of 11.5%.”
Ask for details →InfuSystem Holdings Inc. (ticker: INFU) is a company listed on NYSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 502 employees. Market cap is $182M.
The current price is $8.8 with a P/E ratio of 27.43x and P/B of 3.17x.
ROE is 11.54% and operating margin is 8.31%. Annual revenue is $143M.